Research programme: vaccines - EuBiologics

Drug Profile

Research programme: vaccines - EuBiologics

Alternative Names: EU-C-002 - EuBiologics; EU-C-003 - EuBiologics; EU-C-004 - EuBiologics; EU-V-001 - EuBiologics

Latest Information Update: 09 Aug 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator EuBiologics
  • Class Vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase Unknown Unspecified

Most Recent Events

  • 09 Aug 2016 Investigation in Undefined indication in South Korea (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top